SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-24-000013
Filing Date
2024-06-10
Accepted
2024-06-10 16:10:47
Documents
3
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718050236.html 4  
1 FORM 4 wk-form4_1718050236.xml 4 5837
2 EX-24 poasection16filings-gilb.htm EX-24 4135
3 GRAPHIC poasection16filings-gilb001.jpg GRAPHIC 249996
  Complete submission text file 0001649094-24-000013.txt   355962
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Gilbert Halley E (Reporting) CIK: 0001601360 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 241032781

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)